Abstract

Transthoracic echocardiography is the primary non-invasive modality for the investigation of heart transplant recipients. It is a versatile tool that provides comprehensive information on cardiac structure and function. Echocardiography is also helpful in diagnosing primary graft dysfunction and evaluating the effectiveness of therapeutic approaches for this condition. In acute rejection, echocardiography is useful with suspected cellular or antibody-mediated rejection, with findings confirmed and quantified by endomyocardial biopsy. For identifying chronic rejection, ultrasound has a more significant role and, in some specific patients (e.g., patients with renal failure), it may offer a role comparable to coronary angiography to identify cardiac allograft vasculopathy. This review highlights the usefulness of echocardiography in evaluating normal graft function and its role in the management of heart transplant recipients.

Highlights

  • Heart transplantation remains the gold-standard therapy for patients with advanced heart failure despite optimal medical treatment [1]

  • Over the past four decades, remarkable advances in diagnostic methods for early identification of acute and chronic rejection and in immunosuppressive therapy have resulted in a marked increase in long-term survival, with a current one-year survival rate after heart transplantation of 90% and a conditional half-life of over 13 years [2]

  • Echocardiography is a fundamental tool for adequately managing heart transplant recipients (HTRs), from monitoring the immediate post-operative period to surveillance of early and late post-transplant complications [3]

Read more

Summary

Introduction

Heart transplantation remains the gold-standard therapy for patients with advanced heart failure despite optimal medical treatment [1]. Over the past four decades, remarkable advances in diagnostic methods for early identification of acute and chronic rejection and in immunosuppressive therapy have resulted in a marked increase in long-term survival, with a current one-year survival rate after heart transplantation of 90% and a conditional half-life of over 13 years [2]. Echocardiography is a fundamental tool for adequately managing heart transplant recipients (HTRs), from monitoring the immediate post-operative period to surveillance of early and late post-transplant complications [3]. This review summarizes the basic principles for using echocardiography in cardiac transplant patients to allow even cardiologists not experienced in transplantation to apply this technology in the management of HTR correctly

Normal Cardiac Allograft Structure and Function
Role of Echocardiography in the Evaluation of Acute Graft Rejection
Histopathological Findings No rejection
Role of Echocardiography in the Evaluation of Cardiac Allograft Vasculopathy
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.